All Title Author
Keywords Abstract

PLOS ONE  2013 

Molecular Longitudinal Tracking of Mycobacterium abscessus spp. during Chronic Infection of the Human Lung

DOI: 10.1371/journal.pone.0063237

Full-Text   Cite this paper   Add to My Lib


The Mycobacterium abscessus complex is an emerging cause of chronic pulmonary infection in patients with underlying lung disease. The M. abscessus complex is regarded as an environmental pathogen but its molecular adaptation to the human lung during long-term infection is poorly understood. Here we carried out a longitudinal molecular epidemiological analysis of 178 M. abscessus spp. isolates obtained from 10 cystic fibrosis (CF) and 2 non CF patients over a 13 year period. Multi-locus sequence and molecular typing analysis revealed that 11 of 12 patients were persistently colonized with the same genotype during the course of the infection while replacement of a M. abscessus sensu stricto strain with a Mycobacterium massiliense strain was observed for a single patient. Of note, several patients including a pair of siblings were colonized with closely-related strains consistent with intra-familial transmission or a common infection reservoir. In general, a switch from smooth to rough colony morphology was observed during the course of long-term infection, which in some cases correlated with an increasing severity of clinical symptoms. To examine evolution during long-term infection of the CF lung we compared the genome sequences of 6 sequential isolates of Mycobacterium bolletii obtained from a single patient over an 11 year period, revealing a heterogeneous clonal infecting population with mutations in regulators controlling the expression of virulence factors and complex lipids. Taken together, these data provide new insights into the epidemiology of M. abscessus spp. during long-term infection of the CF lung, and the molecular transition from saprophytic organism to human pathogen.


[1]  Aitken ML, Limaye A, Pottinger P, Whimbey E, Goss CH, et al. (2012) Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. American Journal of Respiratory and Critical Care Medicine 185: 231–232.
[2]  Esther CR, Esserman DA, Gilligan P, Kerr A, Noone PG (2010) Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. Journal of cystic fibrosis: official journal of the European Cystic Fibrosis Society 9: 117–123.
[3]  Viana-Niero C, Lima KVB, Lopes ML, Rabello MC da S, Marsola LR, et al. (2008) Molecular characterization of Mycobacterium massiliense and Mycobacterium bolletii in isolates collected from outbreaks of infections after laparoscopic surgeries and cosmetic procedures. Journal of clinical microbiology 46: 850–855.
[4]  Galil K, Miller LA, Yakrus MA, Wallace RJ, Mosley DG, et al. (1999) Abscesses due to Mycobacterium abscessus linked to injection of unapproved alternative medication. Emerging infectious diseases 5: 681–687.
[5]  Olivier KN, Weber DJ, Wallace RJ, Faiz AR, Lee J-H, et al. (2003) Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. American journal of respiratory and critical care medicine 167: 828–834.
[6]  J?nsson BE, Gilljam M, Lindblad A, Ridell M, Wold AE, et al. (2007) Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis. Journal of clinical microbiology 45: 1497–1504.
[7]  Bastian S, Veziris N, Roux A-L, Brossier F, Gaillard J-L, et al. (2011) Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing. Antimicrobial agents and chemotherapy 55: 775–781.
[8]  Macheras E, Roux A-L, Ripoll F, Sivadon-Tardy V, Gutierrez C, et al. (2009) Inaccuracy of single-target sequencing for discriminating species of the Mycobacterium abscessus group. Journal of clinical microbiology 47: 2596–2600.
[9]  Macheras E, Roux A-L, Bastian S, Le?o SC, Palaci M, et al. (2011) Multilocus sequence analysis and rpoB sequencing of Mycobacterium abscessus (sensu lato) strains. Journal of clinical microbiology 49: 491–499.
[10]  Cigana C, Curcurù L, Leone MR, Ieranò T, Lorè NI, et al. (2009) Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection. PloS one 4: e8439.
[11]  H?ussler S, Tümmler B, Weissbrodt H, Rohde M, Steinmetz I (1999) Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. Clinical infectious diseases; an official publication of the Infectious Diseases Society of America 29: 621–625.
[12]  McAdam PR, Holmes A, Templeton KE, Fitzgerald JR (2011) Adaptive Evolution of Staphylococcus aureus during Chronic Endobronchial Infection of a Cystic Fibrosis Patient. PLoS ONE 6: e24301.
[13]  Kuo Y-M, Cheng A, Wu P-C, Hsieh S-C, Hsieh S-M, et al. (2011) Disseminated Mycobacterium abscessus infection and showerheads, Taiwan. Emerging infectious diseases 17: 2077–2078.
[14]  Falkinham JO, Norton CD, LeChevallier MW (2001) Factors influencing numbers of Mycobacterium avium, Mycobacterium intracellulare, and other Mycobacteria in drinking water distribution systems. Applied and environmental microbiology 67: 1225–1231.
[15]  Nessar R, Cambau E, Reyrat JM, Murray A, Gicquel B (2012) Mycobacterium abscessus: a new antibiotic nightmare. The Journal of antimicrobial chemotherapy 67: 810–818.
[16]  Maurer FP, Rüegger V, Ritter C, Bloemberg G V, B?ttger EC (2012) Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41). The Journal of antimicrobial chemotherapy 67: 2606–2611.
[17]  Sanguinetti M, Ardito F, Fiscarelli E, La Sorda M, D’Argenio P, et al. (2001) Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. Journal of clinical microbiology 39: 816–819.
[18]  Catherinot E, Roux A-L, Macheras E, Hubert D, Matmar M, et al. (2009) Acute respiratory failure involving an R variant of Mycobacterium abscessus. Journal of clinical microbiology 47: 271–274.
[19]  Harris KA, Kenna DTD, Blauwendraat C, Hartley JC, Turton JF, et al. (2012) Molecular fingerprinting of Mycobacterium abscessus strains in a cohort of pediatric cystic fibrosis patients. Journal of clinical microbiology 50: 1758–1761.
[20]  Van Soolingen D, Hermans PW, De Haas PE, Soll DR, Van Embden JD (1991) Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. Journal of clinical microbiology 29: 2578–2586.
[21]  Sampaio JLM, Viana-Niero C, De Freitas D, H?fling-Lima AL, Le?o SC (2006) Enterobacterial repetitive intergenic consensus PCR is a useful tool for typing Mycobacterium chelonae and Mycobacterium abscessus isolates. Diagnostic microbiology and infectious disease 55: 107–118.
[22]  Sechi LA, Zanetti S, Dupré I, Delogu G, Fadda G (1998) Enterobacterial repetitive intergenic consensus sequences as molecular targets for typing of Mycobacterium tuberculosis strains. Journal of clinical microbiology 36: 128–132.
[23]  Kearse M, Moir R, Wilson A, Stones-Havas S, Cheung M, et al. (2012) Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics (Oxford, England) 28: 1647–1649.
[24]  Gordon A (2010) FASTX-toolkit. Available: Accessed 2013 Apr 11.
[25]  Choi G-E, Cho Y-J, Koh W-J, Chun J, Cho S-N, et al. (2012) Draft genome sequence of Mycobacterium abscessus subsp. bolletii BD(T). Journal of bacteriology 194: 2756–2757.
[26]  Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754–1760.
[27]  Bange FC, Brown BA, Smaczny C, Wallace Jr RJ, B?ttger EC (2001) Lack of transmission of Mycobacterium abscessus among patients with cystic fibrosis attending a single clinic. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 32: 1648–1650.
[28]  Cullen AR, Cannon CL, Mark EJ, Colin AA (2000) Mycobacterium abscessus infection in cystic fibrosis. Colonization or infection? American journal of respiratory and critical care medicine 161: 641–645.
[29]  Kim H-Y, Kook Y, Yun Y-J, Park CG, Lee NY, et al. (2008) Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates. Journal of clinical microbiology 46: 3384–3390.
[30]  Zelazny AM, Root JM, Shea YR, Colombo RE, Shamputa IC, et al. (2009) Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii. Journal of clinical microbiology 47: 1985–1995.
[31]  Maloney S, Welbel S, Daves B, Adams K, Becker S, et al. (1994) Mycobacterium abscessus pseudoinfection traced to an automated endoscope washer: utility of epidemiologic and laboratory investigation. The Journal of infectious diseases 169: 1166–1169.
[32]  Fraser VJ, Jones M, Murray PR, Medoff G, Zhang Y, et al. (1992) Contamination of flexible fiberoptic bronchoscopes with Mycobacterium chelonae linked to an automated bronchoscope disinfection machine. The American review of respiratory disease 145: 853–855.
[33]  Huang W-C, Chiou C-S, Chen J-H, Shen G-H (2010) Molecular epidemiology of Mycobacterium abscessus infections in a subtropical chronic ventilatory setting. Journal of medical microbiology 59: 1203–1211.
[34]  Catherinot E, Clarissou J, Etienne G, Ripoll F, Emile J-F, et al. (2007) Hypervirulence of a rough variant of the Mycobacterium abscessus type strain. Infection and immunity 75: 1055–1058.
[35]  Nash KA, Brown-Elliott BA, Wallace RJ (2009) A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrobial agents and chemotherapy 53: 1367–1376.
[36]  Adékambi T, Drancourt M (2009) Mycobacterium bolletii respiratory infections. Emerging infectious diseases 15: 302–305.
[37]  Silbert S, Barth AL, Sader HS (2001) Heterogeneity of Pseudomonas aeruginosa in Brazilian cystic fibrosis patients. Journal of clinical microbiology 39: 3976–3981.
[38]  Lieberman TD, Michel J-B, Aingaran M, Potter-Bynoe G, Roux D, et al. (2011) Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nature genetics 43: 1275–1280.
[39]  Walters SB, Dubnau E, Kolesnikova I, Laval F, Daffe M, et al. (2006) The Mycobacterium tuberculosis PhoPR two-component system regulates genes essential for virulence and complex lipid biosynthesis. Molecular microbiology 60: 312–330.
[40]  Medjahed H, Reyrat J-M (2009) Construction of Mycobacterium abscessus defined glycopeptidolipid mutants: comparison of genetic tools. Applied and environmental microbiology 75: 1331–1338.
[41]  Nessar R, Reyrat J-M, Davidson LB, Byrd TF (2011) Deletion of the mmpL4b gene in the Mycobacterium abscessus glycopeptidolipid biosynthetic pathway results in loss of surface colonization capability, but enhanced ability to replicate in human macrophages and stimulate their innate immune response. Microbiology (Reading, England) 157: 1187–1195.
[42]  Georghiou SB, Magana M, Garfein RS, Catanzaro DG, Catanzaro A, et al. (2012) Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. PloS one 7: e33275.


comments powered by Disqus